Pure Global AI
Disease / condition

Diabetes Mellitus, Type 2 clinical trials

Free access to 1,659 studies10+ countriesUpdated daily164 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
1,659
Total trials
10+
Countries
10+
Sponsors
164
Recruiting
By phase
N/A779
Phase 3293
Phase 1215
Phase 4206
Phase 2127
By status
Completed1,097
Recruiting164
Not yet recruit...142
Unknown89
Terminated78
Top countries
United States of America379
China74
Germany72
Japan58
South Korea56
Top sponsors
Novo Nordisk A/S189
Eli Lilly and Comp...113
Boehringer Ingelhe...113
GlaxoSmithKline95
Sanofi76
Recent trials
Latest clinical trials for Diabetes Mellitus, Type 2
Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
Novo Nordisk A/S · Germany
NCT06403761Not yet recr...
Phase
Phase 1
The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes
Peking University People's Hos...
NCT06408532Not yet recr...
Phase
Phase 4
Economic Evaluation of a Multistage Shared Decision-making Program for Type 2 Diabetes: a Pilot Study
Maastricht University Medical ... · Netherlands
NCT06410768Enrolling by...
A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
Eli Lilly and Company · India
NCT06370715Recruiting
Phase
Phase 4
A Research Study Looking Into Blood Levels of the Medicine NNC0519-0130 in the Body in Participants With Normal or Reduced Kidney Function
Novo Nordisk A/S · Germany
NCT06370819Recruiting
Phase
Phase 1
SugarVita: a Digital Board Game
Maxima Medical Center · Netherlands
NCT06392178Recruiting
Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)
Novo Nordisk A/S · China
NCT06351748Enrolling by...
The Effect of Mankai on Glycemic Control Among Patients With T2D
Ben-Gurion University of the N... · Israel
NCT06416475Recruitment ...
Phase
Phase 2
OASIS: Peer Support for T2DM in Appalachia (Peer Participant)
University of Kentucky · United States of America
NCT06336122Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
Novo Nordisk A/S · Australia,Canada,India,Japan,South Africa,South Korea,United States of America
NCT06326047Recruiting
Phase
Phase 2
A 12-week Digital Physical Activity Programme, With or Without Physical Education Support for Type 2 Diabetes Patients.
Queen Margaret University · United Kingdom
NCT06402578Not yet recr...
Doxycycline in Type II Diabetes
Mostafa Bahaa
NCT06329882Not yet recr...
Phase
Phase 1/2
Testing New Models of Diabetes Self-Management to Improve Population Health
Texas A&M University · United States of America
NCT06370494Completed
Effects of Vitamin D3 and Prebiotics Supplementation on Cardiovascular Risk Factors in Patients With Type 2 Diabetes
Huazhong University of Science...
NCT06351566Not yet recr...
Strategies to Improve Well-Being and Diabetes Management
Elizabeth Scharnetzki · United States of America
NCT06348238Not yet recr...
Effect of Continuing Versus Holding Metformin During Hospitalizations.
University of Illinois at Chic... · United States of America
NCT06296836Not yet recr...
Phase
Phase 4
A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting
Novo Nordisk A/S · Austria
NCT06288412Not yet recr...
Phase
Phase 1
The Effect Of Acupressure and Foot Exercise on Ankle Brachial Index in Individuals With Type 2 Diabetes
Abant Izzet Baysal University
NCT06271382Not yet recr...
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Eli Lilly and Company · Argentina,Canada,Mexico,Puerto Rico,United States of America
NCT06260722Recruiting
Phase
Phase 3
The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin
Aalborg University Hospital · Denmark
NCT06333080Recruiting
View all 1,659 trials →
About this profile

Access comprehensive clinical trial information for Diabetes Mellitus, Type 2 through Pure Global AI's free database. This collection includes 1,659 clinical trials across multiple phases including N/A, Phase 3, Phase 1. Currently, 164 trials are actively recruiting participants.

Research for Diabetes Mellitus, Type 2 is being conducted in United States of America, China, Germany and 7+ other countries. Leading sponsors include Novo Nordisk A/S and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 1,659 clinical trials studying Diabetes Mellitus, Type 2, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Novo Nordisk A/S, Eli Lilly and Company, Boehringer Ingelheim, among others.